摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,5-三嗪-2,4,6-三甲酸三乙酯 | 898-22-6

中文名称
1,3,5-三嗪-2,4,6-三甲酸三乙酯
中文别名
1,3,5三乙酯三嗪-2,4,6-三羧酸
英文名称
triethyl 1,3,5-triazine-2,4,6-tricarboxylate
英文别名
2,4,6-tris(ethoxycarbonyl)-1,3,5-triazine;2,4,6-triethoxycarbonyl-1,3,5-triazine
1,3,5-三嗪-2,4,6-三甲酸三乙酯化学式
CAS
898-22-6
化学式
C12H15N3O6
mdl
MFCD01419268
分子量
297.268
InChiKey
LKNPNZKIOSOWES-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    170-174 °C(lit.)
  • 沸点:
    451.1±28.0 °C(Predicted)
  • 密度:
    1.279±0.06 g/cm3(Predicted)
  • 稳定性/保质期:
    在常温常压下保持稳定

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    21
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    118
  • 氢给体数:
    0
  • 氢受体数:
    9

安全信息

  • 安全说明:
    S22,S24/25
  • 海关编码:
    2933699090
  • WGK Germany:
    3
  • 危险性防范说明:
    P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    常温、避光、存放在通风干燥处。

SDS

SDS:50e239b42c75238338b5bc4df04c7ca9
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product name : Triethyl 1,3,5-triazine-2,4,6-tricarboxylate

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a dangerous substance according to GHS.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Formula : C12H15N3O6
Molecular Weight : 297,26 g/mol
CAS-No. EC-No. Index-No. Classification Concentration
Triethyl-1,3,5-triazine-2,4,6-tricarboxylate
898-22-6 - - - -

Section 4. FIRST AID MEASURES
If inhaled
If breathed in, move person into fresh air. If not breathing give artificial respiration
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Avoid dust formation.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire
protection.
Conditions for safe storage
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Personal protective equipment
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use
type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and approved
under appropriate government standards such as NIOSH (US) or CEN (EU).
Hand protection
For prolonged or repeated contact use protective gloves.
Eye protection
Safety glasses
Hygiene measures
General industrial hygiene practice.

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Form solid
Safety data
pH no data available
Melting point 170 - 174 °C - lit.
Boiling point no data available
Flash point no data available
Ignition temperature no data available
Lower explosion limit no data available
Upper explosion limit no data available
Water solubility no data available

Section 10. STABILITY AND REACTIVITY
Chemical stability
Stable under recommended storage conditions.
Conditions to avoid
no data available
Materials to avoid
Strong oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx)

Section 11. TOXICOLOGICAL INFORMATION
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes
May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Additional Information
RTECS: no data available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Product
Observe all federal, state, and local environmental regulations.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
ADR/RID
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Compounds having a plurality of nitrogenous substitutents
    摘要:
    具有以下公式的新化合物: 其中所述组分变量在此处定义。这些化合物被构建为包括一个中心芳香、脂肪或杂环环系统。连接到中心环系统的是两个具有氮基团的线性基团,这些基团经过化学官能团衍生。环系统可以包括进一步的氮基团,可以作为环原子或连接到环上的侧链基团,这些基团也可以经过化学官能团衍生。化学官能团的总体赋予这些化合物某些构象和其他性质。根据本发明的某些实施例,利用化学官能团和氮基团的排列组合制备这类化合物的文库,以在文库中构建复杂性。
    公开号:
    US06329523B1
  • 作为产物:
    描述:
    氰基甲酸乙酯盐酸 作用下, 反应 72.0h, 以63.1%的产率得到1,3,5-三嗪-2,4,6-三甲酸三乙酯
    参考文献:
    名称:
    1-烷氧基取代的腈的前体化合物4-烷氧基-1,3-恶唑-5(2 H)-ones的合成
    摘要:
    通过两种不同的方法合成了类型4和7的4-烷氧基-1,3-恶唑-5(2 H)- :4-(苯硫基)-1,3-恶唑-5(2 H)-的氧化一个图2a与米在醇的存在下氯过苯甲酸,得到相应的4-烷氧基衍生物4,据推测通过中间亚砜(的亲核取代反应路线2)。第二种方法是BF 3催化的6型亚氨基乙酸与酮的缩合反应(方案3)。由于竞争性地形成了1,3,5-三嗪三羧酸酯8,因此这种更直接的方法的收率不高。在155°下,1,3-恶唑-5(2 H)-一个7b进行了脱羧反应,形成了烷氧基-这是由三氟苯乙酮被困在1,3-偶极环加成,得到二氢恶唑取代的腈叶立德顺-和反式- 9(方案4)。在不存在偶极亲子的情况下,中间体腈基叶立德的1,5-偶极环化产生异吲哚衍生物10(方案4和5)。
    DOI:
    10.1002/hlca.19890720424
  • 作为试剂:
    描述:
    异烟肼1,3,5-三嗪-2,4,6-三甲酸三乙酯 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以0.88 g的产率得到isonicotinoylhydrazide of monoethyloxalate imide
    参考文献:
    名称:
    sym-triazine derivatives. 6. Conversion of 2,4,6-triethoxycarbonyl-1,3,5-triazine with acylhydrazines into 3,5-diethoxycarbonyl-1,2,4-triazole
    摘要:
    DOI:
    10.1007/bf00506080
点击查看最新优质反应信息

文献信息

  • 4-乙胺(2-羧基)-9H-嘧啶并[4,5-b]吲哚及其 制备方法
    申请人:吉林大学
    公开号:CN107353288B
    公开(公告)日:2019-10-18
    本发明涉及有机合成技术领域,具体涉及一种4‑乙胺(2‑羧基)‑9H‑嘧啶并[4,5‑b]吲哚及其制备方法,本发明以4,6‑三乙氧羰基‑1,3,5‑三嗪与2‑氨基吲哚为原料,发生反电子环加成反应得到中间产物,再经过酯基水解选择性脱羧、酰胺缩合反应制得目标产物,工艺简单、目标产物收率高,适合工业化生产,本发明所制备的4‑乙胺(2‑羧基)‑9H‑嘧啶并[4,5‑b]吲哚在治疗心血管疾病、肾病及糖尿病具有潜在的应用。
  • Nitrogenous macrocyclic compounds
    申请人:Isis Pharmaceuticals, Inc.
    公开号:US06107482A1
    公开(公告)日:2000-08-22
    Novel macrocyclic compounds are constructed to include large cyclic structures that are interrupted by at least one ring system. Each interrupting ring system includes two bridgehead atoms. Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical functional groups. The ring systems can include further nitrogenous moieties, either as ring atoms or on pendant groups attached to the ring. These can also be derivatized with chemical functional groups. The totality of the chemical functional groups imparts certain conformational and other properties to the macrocyclic compounds. In accordance with certain embodiments of the invention, libraries of such macrocyclic compounds are prepared utilizing permutations and combinations of the chemical functional groups and the nitrogenous moieties to build complexity into the library.
    新型大环化合物被构建成包含至少一个环系统打断的大环结构。每个打断的环系统包括两个桥头原子。桥头原子与一个或多个桥连接,连接一个或多个环系统,从而形成一个大环结构。每个桥中都含有两个或更多的氮基团,这些氮基团经过化学官能团衍生。环系统可以包括进一步的氮基团,可以是环原子,也可以是连接到环上的侧链基团。这些也可以经过化学官能团衍生。化学官能团的总体赋予大环化合物特定的构象和其他性质。根据发明的某些实施例,利用化学官能团和氮基团的排列组合制备这种大环化合物的文库,以在文库中构建复杂性。
  • Substituted heterocyclic compounds
    申请人:ISIS Pharmaceuticals, Inc.
    公开号:US06077954A1
    公开(公告)日:2000-06-20
    Novel compounds having the formula: ##STR1## wherein the constituent variables are defined herein. The compounds are constructed to include a central aromatic, aliphatic, or heterocyclic ring system. Attached to the central ring system are two linear groups having nitrogenous moieties that are derivatized with chemical functional groups. The ring system can include further nitrogenous moieties, either as ring atoms or on pendant groups attached to the ring, that may also be derivatized with chemical functional groups. The totality of the chemical functional groups imparts certain conformational and other properties to the these compounds. In accordance with certain embodiments of the invention, libraries of such compounds are prepared utilizing permutations and combinations of the chemical functional groups and the nitrogenous moieties to build complexity into the libraries.
    具有以下结构式的新化合物:##STR1## 其中所述变量在此处定义。这些化合物被构建为包括一个中心芳香、脂肪或杂环环系统。连接到中心环系统的是两个线性基团,其具有氮基团,这些氮基团经过化学官能团衍生。环系统可以包括进一步的氮基团,可以作为环原子或连接到环上的侧链基团,这些氮基团也可以经过化学官能团衍生。化学官能团的总体赋予这些化合物某些构象和其他性质。根据本发明的某些实施例,利用化学官能团和氮基团的排列组合制备这类化合物的文库,以在文库中构建复杂性。
  • N-丁基-9H-嘧啶并[4,5-b]吲哚-2-甲酰胺的 制备方法
    申请人:吉林大学
    公开号:CN105037374B
    公开(公告)日:2017-04-12
    本发明涉及嘧啶并[4,5‑b]吲哚类化合物的制备方法,具体地说是N‑丁基‑9H‑嘧啶并[4,5‑b]吲哚‑2‑甲酰胺的制备方法。该化合物是以2,4,6‑三乙氧羰基‑1,3,5‑三嗪与2‑氨基吲哚发生反电子环加成反应得到中间产物,再经过酯基水解脱羧、酰胺缩合反应而得。该化合物对细胞增殖具有抑制作用,可用作多种不同适应症的药物。本发明工艺简单,且目标产物收率高。
  • Regiospecific Syntheses of 3-Aza-α-carbolines via Inverse Electron-Demand Diels-Alder Reactions of 2-Aminoindoles with 1,3,5-Triazines
    作者:Qun Dang、Xu Bai、Guoxing Xu、Lianyou Zheng、Shixue Wang
    DOI:10.1055/s-0029-1218345
    日期:2009.12
    scope of 1,3,5-triazine inverse electron-demand Diels-Alder (IDA) reactions was expanded to include 2-aminoindoles as productive dienophiles leading to various 3-aza-α-carbolines in excellent yields. Furthermore, the two ester groups of the IDA product were differentiated via reduction of the C4-ester to its corresponding alcohol. This new IDA reaction could be potentially applied to the synthesis of
    1,3,5-三嗪逆电子需求 Diels-Alder (IDA) 反应的范围扩大到包括 2-氨基吲哚作为生产亲二烯体,从而以优异的产率获得各种 3-氮杂-α-咔啉。此外,IDA 产品的两个酯基团是通过将 C4-酯还原为其相应的醇来区分的。这种新的 IDA 反应可用于合成各种可能具有神经保护活性的 3-氮杂-mescengrincin 类似物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物